Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-term Infants.

Hascoët JM, Chevallier M, Gire C, Brat R, Rozé JC, Norbert K, Chen Y, Hartweg M, Billeaud C

Open source

DOI
10.3389/fped.2022.858380
Published
2022
Container
Frontiers in pediatrics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2022.858380,
  title = {Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-term Infants.},
  author = {Hascoët JM and Chevallier M and Gire C and Brat R and Rozé JC and Norbert K and Chen Y and Hartweg M and Billeaud C},
  year = {2022},
  journal = {Frontiers in pediatrics},
  doi = {10.3389/fped.2022.858380},
  url = {https://doi.org/10.3389/fped.2022.858380}
}

RIS

TY  - JOUR
TI  - Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-term Infants.
AU  - Hascoët JM
AU  - Chevallier M
AU  - Gire C
AU  - Brat R
AU  - Rozé JC
AU  - Norbert K
AU  - Chen Y
AU  - Hartweg M
AU  - Billeaud C
PY  - 2022
JO  - Frontiers in pediatrics
DO  - 10.3389/fped.2022.858380
UR  - https://doi.org/10.3389/fped.2022.858380
ER  - 

APA

JM, H., M, C., C, G., R, B., JC, R., K, N., Y, C., M, H., & C, B. (2022). Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-term Infants.. Frontiers in pediatrics. https://doi.org/10.3389/fped.2022.858380

Source records